N/A
N=2,521
Cannabis Edibles Packaging Descriptors Experiment
Cannabis Use
Bottom Line
View on ClinicalTrials.gov: NCT06171399 ↗Enrolled (actual)
2,521
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Product Appeal — 6.43; 6.04; 6.04; 6.06 score on a scale 0-10
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- "All Natural" descriptor (Behavioral); "Gluten-free" descriptor (Behavioral); "Vegan" descriptor (Behavioral); "100% Organic" descriptor (Behavioral); "Handcrafted" descriptor (Behavioral); "Made with live resin" descriptor (Behavioral); "Fast-acting" descriptor (Behavioral); "Relax" descriptor (Behavioral); "Energy Boost" descriptor (Behavioral); No descriptor (control) (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Wake Forest University Health Sciences
- Primary completion
- Apr 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Product Appeal |
6.43; 6.04; 6.04; 6.06; 5.73; 6.29 | — |
| PRIMARY Product Harm Perceptions (Absolute) |
53; 67; 81; 65; 95; 75 | — |
| PRIMARY Willingness to Try Free Sample |
168; 215; 210; 193; 234; 190 | — |
| PRIMARY Package Appeal |
6.71; 6.28; 6.34; 6.30; 6.11; 6.56 | — |
| PRIMARY Package Harm Perceptions (Absolute) |
85; 110; 122; 101; 123; 109 | — |
| PRIMARY Willingness to Try Product |
171; 209; 230; 217; 229; 207 | — |
| SECONDARY Appeal to Children Responses |
5.97; 5.71; 5.58; 5.58; 5.34; 5.87 | — |
| SECONDARY Product Harm Perceptions (Relative) |
44; 48; 63; 61; 82; 53 | — |
Summary
The purpose of this study is to assess differences in perceptions of product appeal, harm, and subsequent willingness to try cannabis edibles products with/without product descriptors of interest.
Eligibility Criteria
Inclusion Criteria
- US resident
- Aged 18-65, inclusive
- Up to 13% of participants will be those who identify as Black/African American
- Up to 16% of participants will be those who identify as Hispanic
- Approximately 50% of participants will be past year cannabis users
Exclusion Criteria
- Does not currently reside in the United States
- Younger than 18 or older than 65
- Does not provide information regarding history of cannabis use
- Otherwise eligible but demographic and/or user group quotas have been met
Data sourced from ClinicalTrials.gov (NCT06171399). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.